• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆分析中条件协方差比较问题的功能视角

A FUNCTIONAL PERSPECTIVE ON THE CONDITIONAL COVARIANCE COMPARISON PROBLEM IN DEMENTIA ANALYSIS.

作者信息

Guan Calvin, Gangopadhyay Ashis

机构信息

Department of Mathematics & Statistics, Boston University.

出版信息

bioRxiv. 2025 May 18:2023.12.19.572366. doi: 10.1101/2023.12.19.572366.

DOI:10.1101/2023.12.19.572366
PMID:40463050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12132494/
Abstract

Although there are many methods available in the literature to compare the covariance structures of two populations, few are suitable for clinical application due to the inability to account for covariate(s) that affect the dependence structure of the variables being investigated. A common method is to adjust the effect of the covariates via a linear model and work with the resulting residuals. However, removing the effects of the covariates could potentially eliminate valuable information from the analysis. We propose a functional nonparametric covariance matrix estimator to account for any given value in the covariate(s), which allows a comparison of the functional covariance structures of the multivariate data. This comparison is facilitated via a test statistic involving the first eigenvalue of the combined form of covariance matrices of the two groups. Three different approaches, namely, the parametric Tracy-Widom, the semi-parametric Forkman's test, and the nonparametric Permutation method, are used to compute the approximate p-values of the test statistic. We have conducted extensive simulation studies to determine the type I error and power of the proposed hypothesis testing methods and developed practical recommendations for implementing this novel approach. Finally, we apply our methods to the Alzheimer's Disease Neuroimaging Initiative (ADNI) study to compare cerebrospinal fluid (CSF) biomarkers between dementia and non-dementia cohorts, which offers a fascinating insight into the differences between covariance structures of biomarkers amyloid , total tau (tau), and phosphorylated tau (ptau) for given values of age, sex, and years of education.

摘要

虽然文献中有许多方法可用于比较两个总体的协方差结构,但由于无法考虑影响所研究变量依赖结构的协变量,很少有方法适用于临床应用。一种常见的方法是通过线性模型调整协变量的影响,并处理由此产生的残差。然而,去除协变量的影响可能会从分析中潜在地消除有价值的信息。我们提出了一种函数非参数协方差矩阵估计器,以考虑协变量中的任何给定值,这使得能够比较多变量数据的函数协方差结构。通过涉及两组协方差矩阵组合形式的第一个特征值的检验统计量来促进这种比较。使用三种不同的方法,即参数化的特雷西 - 威多姆方法、半参数化的福克曼检验和非参数化的置换方法,来计算检验统计量的近似p值。我们进行了广泛的模拟研究,以确定所提出的假设检验方法的I型错误和功效,并为实施这种新方法制定了实用建议。最后,我们将我们的方法应用于阿尔茨海默病神经影像学倡议(ADNI)研究,以比较痴呆症和非痴呆症队列之间的脑脊液(CSF)生物标志物,这为在年龄、性别和受教育年限的给定值下,生物标志物淀粉样蛋白、总tau蛋白(tau)和磷酸化tau蛋白(ptau)的协方差结构差异提供了引人入胜的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/cc3ad0122ae0/nihpp-2023.12.19.572366v2-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/30bef6b75d11/nihpp-2023.12.19.572366v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/666dfa258c46/nihpp-2023.12.19.572366v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/e65c5e0efe3d/nihpp-2023.12.19.572366v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/a6f360b70498/nihpp-2023.12.19.572366v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/f9b07371d5f6/nihpp-2023.12.19.572366v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/48c0d18c9dee/nihpp-2023.12.19.572366v2-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/505bc1a08c4c/nihpp-2023.12.19.572366v2-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/826c284276a6/nihpp-2023.12.19.572366v2-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/bec1a277beed/nihpp-2023.12.19.572366v2-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/4dbd98ccd75d/nihpp-2023.12.19.572366v2-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/3aa3a9b2e50e/nihpp-2023.12.19.572366v2-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/cc3ad0122ae0/nihpp-2023.12.19.572366v2-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/30bef6b75d11/nihpp-2023.12.19.572366v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/666dfa258c46/nihpp-2023.12.19.572366v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/e65c5e0efe3d/nihpp-2023.12.19.572366v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/a6f360b70498/nihpp-2023.12.19.572366v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/f9b07371d5f6/nihpp-2023.12.19.572366v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/48c0d18c9dee/nihpp-2023.12.19.572366v2-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/505bc1a08c4c/nihpp-2023.12.19.572366v2-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/826c284276a6/nihpp-2023.12.19.572366v2-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/bec1a277beed/nihpp-2023.12.19.572366v2-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/4dbd98ccd75d/nihpp-2023.12.19.572366v2-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/3aa3a9b2e50e/nihpp-2023.12.19.572366v2-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e5/12132494/cc3ad0122ae0/nihpp-2023.12.19.572366v2-f0012.jpg

相似文献

1
A FUNCTIONAL PERSPECTIVE ON THE CONDITIONAL COVARIANCE COMPARISON PROBLEM IN DEMENTIA ANALYSIS.痴呆分析中条件协方差比较问题的功能视角
bioRxiv. 2025 May 18:2023.12.19.572366. doi: 10.1101/2023.12.19.572366.
2
Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.泰国诗里拉吉医院对阿尔茨海默病(AD)及其他痴呆症患者的脑脊液(CSF)β-淀粉样蛋白(1-42)、磷酸化tau蛋白(ptau-181)和总tau蛋白进行评估。
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers.跨性别脑磁共振成像特征与脑脊液阿尔茨海默病生物标志物
Brain Commun. 2025 May 30;7(3):fcaf210. doi: 10.1093/braincomms/fcaf210. eCollection 2025.
6
Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants.黑人和/或非裔美国人阿尔茨海默病神经影像学倡议(ADNI)参与者的阿尔茨海默病生物标志物。
Neurobiol Aging. 2023 Nov;131:144-152. doi: 10.1016/j.neurobiolaging.2023.07.021. Epub 2023 Jul 20.
7
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
8
Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.基于生物标志物的 MCI 进展预测:AD 特征和海马体积与脑脊液淀粉样蛋白-β和 tau 的比较。
Front Aging Neurosci. 2013 Oct 11;5:55. doi: 10.3389/fnagi.2013.00055. eCollection 2013.
9
Minimax Powerful Functional Analysis of Covariance Tests: with Application to Longitudinal Genome-Wide Association Studies.协方差检验的极小极大功效函数分析:及其在纵向全基因组关联研究中的应用
Scand Stat Theory Appl. 2023 Mar;50(1):266-295. doi: 10.1111/sjos.12583. Epub 2022 Mar 13.
10
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.阿尔茨海默病脑脊液生物标志物可预测路易体痴呆的认知衰退。
Mov Disord. 2016 Aug;31(8):1203-8. doi: 10.1002/mds.26668. Epub 2016 Jun 14.

本文引用的文献

1
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.血浆磷酸化 tau 217 和磷酸化 tau 181 作为阿尔茨海默病和额颞叶变性的生物标志物:一项回顾性诊断性能研究。
Lancet Neurol. 2021 Sep;20(9):739-752. doi: 10.1016/S1474-4422(21)00214-3.
2
Sex differences in CSF biomarkers vary by Alzheimer disease stage and ε4 genotype.性别差异在 CSF 生物标志物中因阿尔茨海默病阶段和 ε4 基因型而异。
Neurology. 2020 Oct 27;95(17):e2378-e2388. doi: 10.1212/WNL.0000000000010629. Epub 2020 Aug 11.
3
Inflammatory biomarkers in Alzheimer's disease plasma.
阿尔茨海默病患者血浆中的炎症生物标志物。
Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30.
4
Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review.阿尔茨海默病患者死后脑组织样本中微胶质细胞标志物的系统评价。
Mol Psychiatry. 2018 Feb;23(2):177-198. doi: 10.1038/mp.2017.246. Epub 2017 Dec 12.
5
A global test for gene-gene interactions based on random matrix theory.基于随机矩阵理论的基因-基因相互作用全局检验。
Genet Epidemiol. 2016 Dec;40(8):689-701. doi: 10.1002/gepi.21990. Epub 2016 Jul 7.
6
The role of neuroinflammation in dementias.神经炎症在痴呆症中的作用。
Curr Neurol Neurosci Rep. 2015 Apr;15(4):17. doi: 10.1007/s11910-015-0531-7.
7
Log-transformation and its implications for data analysis.对数变换及其对数据分析的影响。
Shanghai Arch Psychiatry. 2014 Apr;26(2):105-9. doi: 10.3969/j.issn.1002-0829.2014.02.009.
8
Systematic review of methods for individual patient data meta- analysis with binary outcomes.二元结局个体患者数据荟萃分析方法的系统评价
BMC Med Res Methodol. 2014 Jun 19;14:79. doi: 10.1186/1471-2288-14-79.
9
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints.脑脊液 Aβ42 是有主观症状的患者临床进展的最佳预测指标。
Alzheimers Dement. 2013 Sep;9(5):481-7. doi: 10.1016/j.jalz.2012.08.004. Epub 2012 Dec 8.
10
NONPARAMETRIC COVARIANCE MODEL.非参数协方差模型
Stat Sin. 2010;20:469-479.